Ventyx Biosciences, Inc. (VTYX) Discusses Constructive Section II Outcomes of VTX3232 in Weight problems and Cardiovascular Threat Elements Transcript

FollowPlay Earnings CallPlay Earnings Call

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Discusses Positive Phase II Results of VTX3232 in Obesity and Cardiovascular Risk Factors October 22, 2025 4:30 PM EDT

Company Participants

Alex Schwartz
Raju Mohan – Founder, CEO, President & Director
Mark Forman
Roy Gonzales – Senior VP of Finance and Principal Financial & Accounting Officer

Conference Call Participants

Antonio Abbate
Peter Libby
Lin Tsai – Jefferies LLC, Research Division
Samuel Slutsky – LifeSci Capital, LLC, Research Division
Yasmeen Rahimi – Piper Sandler & Co., Research Division
Derek Archila – Wells Fargo Securities, LLC, Research Division
Jeffrey Jones – Oppenheimer & Co. Inc., Research Division
Alexander Thompson – Stifel, Nicolaus & Company, Incorporated, Research Division

Presentation

Operator

Good day, everyone, and welcome to today’s Ventyx business update call. (Operator Instructions) Today’s call is being recorded. I will stand by should you need any assistance. It is now my pleasure to turn the conference over to Mr. Alex Schwartz. Please go ahead, sir.

Alex Schwartz

Thank you, Sherry. Hello, everyone. Thank you for joining us today. Before we discuss the Phase II study results in greater detail, we have some preliminary items to cover. First, I’d like to know the VTX3232 results press release is now available on our website, ventyxbio.com. Second, the slides that are being presented today are currently available on webcast. Following conclusion of our webcast, the slides will be posted on our website.

Next, on Slide 2. I’d like to remind the audience that during this call, we will be making forward-looking statements under the Safe Harbor Act. These forward-looking statements are based on current information, assumptions and expectations that are subject to change and involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These and other risk factors can be found in our most recent Form 10-K and Form 10-Q filed with the SEC. And as

Source link